Home › Funds › Balyasny Asset Management › ABVX
Balyasny Asset Management position in ABVX
ABIVAX SA · Health Care
Latest position (Q2 2026)624.44K sh
Reported value held$83.21M
Portfolio Weight0.11%
First reportedQ3 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 160.22K | $13.60M | New |
| Q4 2025 | 493.32K | $66.53M | Add |
| Q1 2026 | 213.69K | $23.79M | Reduce |
| Q2 2026 | 624.44K | $83.21M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ABVX
- Citadel Advisors 4.24M sh · $565.52M · Q2 2026
- UBS Group AG 1.86M sh · $247.95M · Q2 2026
- Morgan Stanley 1.43M sh · $190.85M · Q2 2026
- Norges Bank Investment Management 1.10M sh · $146.59M · Q2 2026
- Bank of America Corp 971.44K sh · $129.45M · Q2 2026
- Goldman Sachs Group 792.71K sh · $105.64M · Q2 2026
- Janus Henderson Group 878.83K sh · $98.01M · Q1 2026
- BlackRock Inc 574.06K sh · $76.50M · Q2 2026
- Millennium Management 307.64K sh · $41.00M · Q2 2026
- Franklin Resources 299.75K sh · $39.95M · Q2 2026
- Principal Global Investors 257.68K sh · $34.34M · Q2 2026